Nucleo-cytoplasmic shuttling of progesterone receptor and cell cycle progression of breast cancer cells.
Giovanni Galasso(University of Campania "Luigi Vanvitelli"), Gabriella Castoria(University of Campania "Luigi Vanvitelli"), Antimo Migliaccio(University of Campania "Luigi Vanvitelli"), Pia Giovannelli(University of Campania "Luigi Vanvitelli"), Marzia Di Donato(University of Campania "Luigi Vanvitelli"), Roberto Garbo(Santa Maria Nuova Hospital), Erika Di Zazzo(University of Molise), Bruno Perillo(Institute of Food Science)
PubMed
January 1, 2000
Cited by 0
Related Papers
ROS in cancer therapy: the bright side of the moon
|Experimental & Molecular Medicine|2020|2.2k
The Androgen Receptor in Breast Cancer
|Frontiers in Endocrinology|2018|206
Adiponectin as Link Factor between Adipose Tissue and Cancer
|International Journal of Molecular Sciences|2019|138
Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications
|Frontiers in Oncology|2018|126